vs
Side-by-side financial comparison of BANCFIRST CORP (BANF) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $181.0M, roughly 1.0× BANCFIRST CORP). BANCFIRST CORP runs the higher net margin — 32.9% vs 0.9%, a 32.0% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 11.1%). BANCFIRST CORP produced more free cash flow last quarter ($237.0M vs $16.0M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 9.5%).
BancFirst Corporation is an Oklahoma-based financial services holding company. The company operates three subsidiary banks, BancFirst, an Oklahoma state-chartered bank; and Pegasus Bank and Worthington Bank, both Texas state-chartered banks.
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
BANF vs FOLD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $181.0M | $185.2M |
| Net Profit | $59.5M | $1.7M |
| Gross Margin | — | 85.7% |
| Operating Margin | 41.6% | 8.6% |
| Net Margin | 32.9% | 0.9% |
| Revenue YoY | 11.1% | 23.7% |
| Net Profit YoY | 5.3% | -88.5% |
| EPS (diluted) | $1.75 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $181.0M | $185.2M | ||
| Q3 25 | $175.5M | $169.1M | ||
| Q2 25 | $169.3M | $154.7M | ||
| Q1 25 | $164.8M | $125.2M | ||
| Q4 24 | $162.9M | $149.7M | ||
| Q3 24 | $163.7M | $141.5M | ||
| Q2 24 | $153.8M | $126.7M | ||
| Q1 24 | $151.0M | $110.4M |
| Q4 25 | $59.5M | $1.7M | ||
| Q3 25 | $62.7M | $17.3M | ||
| Q2 25 | $62.3M | $-24.4M | ||
| Q1 25 | $56.1M | $-21.7M | ||
| Q4 24 | $56.5M | $14.7M | ||
| Q3 24 | $58.9M | $-6.7M | ||
| Q2 24 | $50.6M | $-15.7M | ||
| Q1 24 | $50.3M | $-48.4M |
| Q4 25 | — | 85.7% | ||
| Q3 25 | — | 88.5% | ||
| Q2 25 | — | 90.2% | ||
| Q1 25 | — | 90.7% | ||
| Q4 24 | — | 90.1% | ||
| Q3 24 | — | 90.6% | ||
| Q2 24 | — | 91.1% | ||
| Q1 24 | — | 87.7% |
| Q4 25 | 41.6% | 8.6% | ||
| Q3 25 | 45.0% | 20.3% | ||
| Q2 25 | 47.1% | -6.1% | ||
| Q1 25 | 43.1% | -6.3% | ||
| Q4 24 | 44.2% | 10.7% | ||
| Q3 24 | 45.2% | 15.3% | ||
| Q2 24 | 42.4% | 11.8% | ||
| Q1 24 | 42.5% | -25.1% |
| Q4 25 | 32.9% | 0.9% | ||
| Q3 25 | 35.7% | 10.2% | ||
| Q2 25 | 36.8% | -15.8% | ||
| Q1 25 | 34.0% | -17.3% | ||
| Q4 24 | 34.7% | 9.8% | ||
| Q3 24 | 36.0% | -4.8% | ||
| Q2 24 | 32.9% | -12.4% | ||
| Q1 24 | 33.3% | -43.9% |
| Q4 25 | $1.75 | $0.00 | ||
| Q3 25 | $1.85 | $0.06 | ||
| Q2 25 | $1.85 | $-0.08 | ||
| Q1 25 | $1.66 | $-0.07 | ||
| Q4 24 | $1.68 | $0.05 | ||
| Q3 24 | $1.75 | $-0.02 | ||
| Q2 24 | $1.51 | $-0.05 | ||
| Q1 24 | $1.50 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $293.5M |
| Total DebtLower is stronger | — | $392.7M |
| Stockholders' EquityBook value | $1.9B | $274.2M |
| Total Assets | $14.8B | $949.9M |
| Debt / EquityLower = less leverage | — | 1.43× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $293.5M | ||
| Q3 25 | — | $263.8M | ||
| Q2 25 | — | $231.0M | ||
| Q1 25 | — | $250.6M | ||
| Q4 24 | — | $249.9M | ||
| Q3 24 | — | $249.8M | ||
| Q2 24 | — | $260.1M | ||
| Q1 24 | — | $239.6M |
| Q4 25 | — | $392.7M | ||
| Q3 25 | — | $392.0M | ||
| Q2 25 | — | $391.3M | ||
| Q1 25 | — | $390.7M | ||
| Q4 24 | — | $390.1M | ||
| Q3 24 | — | $389.5M | ||
| Q2 24 | — | $388.9M | ||
| Q1 24 | — | $388.4M |
| Q4 25 | $1.9B | $274.2M | ||
| Q3 25 | $1.8B | $230.4M | ||
| Q2 25 | $1.7B | $204.3M | ||
| Q1 25 | $1.7B | $193.6M | ||
| Q4 24 | $1.6B | $194.0M | ||
| Q3 24 | $1.6B | $178.8M | ||
| Q2 24 | $1.5B | $132.5M | ||
| Q1 24 | $1.5B | $130.7M |
| Q4 25 | $14.8B | $949.9M | ||
| Q3 25 | $14.2B | $868.8M | ||
| Q2 25 | $14.0B | $815.3M | ||
| Q1 25 | $14.0B | $789.8M | ||
| Q4 24 | $13.6B | $785.0M | ||
| Q3 24 | $13.3B | $786.6M | ||
| Q2 24 | $12.7B | $749.5M | ||
| Q1 24 | $12.6B | $721.8M |
| Q4 25 | — | 1.43× | ||
| Q3 25 | — | 1.70× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.02× | ||
| Q4 24 | — | 2.01× | ||
| Q3 24 | — | 2.18× | ||
| Q2 24 | — | 2.93× | ||
| Q1 24 | — | 2.97× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $285.3M | $16.3M |
| Free Cash FlowOCF − Capex | $237.0M | $16.0M |
| FCF MarginFCF / Revenue | 130.9% | 8.6% |
| Capex IntensityCapex / Revenue | 26.7% | 0.2% |
| Cash ConversionOCF / Net Profit | 4.79× | 9.62× |
| TTM Free Cash FlowTrailing 4 quarters | $430.7M | $29.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $285.3M | $16.3M | ||
| Q3 25 | $75.4M | $35.7M | ||
| Q2 25 | $78.1M | $-26.5M | ||
| Q1 25 | $77.0M | $7.8M | ||
| Q4 24 | $261.2M | $-3.9M | ||
| Q3 24 | $77.6M | $-23.0M | ||
| Q2 24 | $100.2M | $22.7M | ||
| Q1 24 | $66.3M | $-29.7M |
| Q4 25 | $237.0M | $16.0M | ||
| Q3 25 | $63.7M | $35.3M | ||
| Q2 25 | $64.4M | $-28.9M | ||
| Q1 25 | $65.6M | $7.5M | ||
| Q4 24 | $224.5M | $-4.2M | ||
| Q3 24 | $72.4M | $-23.3M | ||
| Q2 24 | $94.1M | $21.6M | ||
| Q1 24 | $56.1M | $-31.5M |
| Q4 25 | 130.9% | 8.6% | ||
| Q3 25 | 36.3% | 20.9% | ||
| Q2 25 | 38.0% | -18.7% | ||
| Q1 25 | 39.8% | 6.0% | ||
| Q4 24 | 137.8% | -2.8% | ||
| Q3 24 | 44.2% | -16.5% | ||
| Q2 24 | 61.2% | 17.0% | ||
| Q1 24 | 37.1% | -28.5% |
| Q4 25 | 26.7% | 0.2% | ||
| Q3 25 | 6.7% | 0.2% | ||
| Q2 25 | 8.1% | 1.6% | ||
| Q1 25 | 6.9% | 0.2% | ||
| Q4 24 | 22.5% | 0.2% | ||
| Q3 24 | 3.2% | 0.3% | ||
| Q2 24 | 3.9% | 0.9% | ||
| Q1 24 | 6.8% | 1.6% |
| Q4 25 | 4.79× | 9.62× | ||
| Q3 25 | 1.20× | 2.06× | ||
| Q2 25 | 1.25× | — | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | 4.62× | -0.27× | ||
| Q3 24 | 1.32× | — | ||
| Q2 24 | 1.98× | — | ||
| Q1 24 | 1.32× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BANF
Segment breakdown not available.
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
